StockStory.org on MSN
Winners and losers of Q4: Insulet (NASDAQ:PODD) vs the rest of the patient monitoring stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...
DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system.
Glucotrack Inc. (NASDAQ:GCTK) stock traded higher on Wednesday, with a session volume of 15.91 million compared to the average of 81.7K, according to data from Benzinga Pro. The diabetes-focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results